These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27354676)

  • 1. Improving patient-centred care for rheumatoid arthritis.
    Bansback N; Shojania K; Lacaille D
    CMAJ; 2016 Oct; 188(14):999-1000. PubMed ID: 27354676
    [No Abstract]   [Full Text] [Related]  

  • 2. The combination of methotrexate, sulfasalazine and hydroxychloroquine is highly effective in rheumatoid arthritis.
    Furst DE
    Clin Exp Rheumatol; 1999; 17(1):39-40. PubMed ID: 10084027
    [No Abstract]   [Full Text] [Related]  

  • 3. Making rational treatment decisions in rheumatoid arthritis when methotrexate fails.
    Bathon JM; McMahon DJ
    N Engl J Med; 2013 Jul; 369(4):384-5. PubMed ID: 23755970
    [No Abstract]   [Full Text] [Related]  

  • 4. Conventional triple therapy as good as etanercept for uncontrolled rheumatoid arthritis.
    BMJ; 2013 Jun; 346():f3846. PubMed ID: 23778977
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of rheumatoid arthritis.
    Stohl W; Arkfeld DG
    N Engl J Med; 1996 Sep; 335(11):821-2; author reply 822-3. PubMed ID: 8778593
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.
    O'Dell JR; Haire CE; Erikson N; Drymalski W; Palmer W; Eckhoff PJ; Garwood V; Maloley P; Klassen LW; Wees S; Klein H; Moore GF
    N Engl J Med; 1996 May; 334(20):1287-91. PubMed ID: 8609945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapies for active rheumatoid arthritis after methotrexate failure.
    O'Dell JR; Mikuls TR; Taylor TH; Ahluwalia V; Brophy M; Warren SR; Lew RA; Cannella AC; Kunkel G; Phibbs CS; Anis AH; Leatherman S; Keystone E;
    N Engl J Med; 2013 Jul; 369(4):307-18. PubMed ID: 23755969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of rheumatoid arthritis.
    Zurier RB; DeMarco DM; Liu NY
    N Engl J Med; 1996 Sep; 335(11):822; author reply 822-3. PubMed ID: 8778595
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination DMARD therapy with hydroxychloroquine, sulfasalazine, and methotrexate.
    O'Dell JR
    Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S53-8. PubMed ID: 10589358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatoid arthritis. Triple therapy or etanercept after methotrexate failure in RA?
    van Vollenhoven RF; Chatzidionysiou K
    Nat Rev Rheumatol; 2013 Sep; 9(9):510-2. PubMed ID: 23897440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial.
    Rantalaiho VM; Kautiainen H; Korpela M; Hannonen PJ; Leirisalo-Repo M; Möttönen T;
    Ann Rheum Dis; 2013 May; 72(5):786-8. PubMed ID: 23349132
    [No Abstract]   [Full Text] [Related]  

  • 12. Etanercept-Methotrexate Combination Therapy Initiators Have Greater Adherence and Persistence Than Triple Therapy Initiators With Rheumatoid Arthritis.
    Bonafede M; Johnson BH; Tang DH; Shah N; Harrison DJ; Collier DH
    Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1656-63. PubMed ID: 26097194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate.
    O'Dell JR; Haire C; Erikson N; Drymalski W; Palmer W; Maloley P; Klassen LW; Wees S; Moore GF
    J Rheumatol Suppl; 1996 Mar; 44():72-4. PubMed ID: 8833058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Update on Current Care Guidelines. Rheumatoid Arthritis (RA)].
    Duodecim; 2015; 131(15):1409-10. PubMed ID: 26433976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
    van Vollenhoven RF; Ernestam S; Geborek P; Petersson IF; Cöster L; Waltbrand E; Zickert A; Theander J; Thörner A; Hellström H; Teleman A; Dackhammar C; Akre F; Forslind K; Ljung L; Oding R; Chatzidionysiou A; Wörnert M; Bratt J
    Lancet; 2009 Aug; 374(9688):459-66. PubMed ID: 19665644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment considerations in early rheumatoid arthritis.
    Schattner A
    J Intern Med; 1997 Jun; 241(6):445-9. PubMed ID: 10497619
    [No Abstract]   [Full Text] [Related]  

  • 17. The changing face of rheumatoid arthritis therapy: results of serial surveys.
    Mikuls TR; O'Dell J
    Arthritis Rheum; 2000 Feb; 43(2):464-5. PubMed ID: 10693890
    [No Abstract]   [Full Text] [Related]  

  • 18. Triple therapy with non-biologic DMARDs for rheumatoid arthritis or biologic therapy. Is it the same?
    Abud-Mendoza C; Martínez-Martínez MU
    Reumatol Clin; 2014; 10(5):345-6. PubMed ID: 24681058
    [No Abstract]   [Full Text] [Related]  

  • 19. A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquine.
    Wojciechowski J; Wiese MD; Proudman SM; Foster DJ; Upton RN
    Br J Clin Pharmacol; 2015 May; 79(5):777-88. PubMed ID: 25394211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of High-Density Lipoprotein Function in Patients With Early Rheumatoid Arthritis Treated With Methotrexate Monotherapy or Combination Therapies in a Randomized Controlled Trial.
    Charles-Schoeman C; Yin Lee Y; Shahbazian A; Wang X; Elashoff D; Curtis JR; Navarro-Millán I; Yang S; Chen L; Cofield SS; Moreland LW; Paulus H; O'Dell J; Bathon J; Louis Bridges S; Reddy ST
    Arthritis Rheumatol; 2017 Jan; 69(1):46-57. PubMed ID: 27483410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.